KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Notes Payables (2017 - 2018)

Astrana Health (ASTH) has disclosed Notes Payables for 4 consecutive years, with $40257.0 as the latest value for Q4 2018.

  • Quarterly Notes Payables fell 92.11% to $40257.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $40257.0 through Dec 2018, down 92.11% year-over-year, with the annual reading at $40257.0 for FY2018, 92.11% down from the prior year.
  • Notes Payables hit $40257.0 in Q4 2018 for Astrana Health, down from $159906.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $4.9 million in Q3 2017 to a low of $40257.0 in Q4 2018.
  • Historically, Notes Payables has averaged $1.9 million across 3 years, with a median of $1.1 million in 2015.
  • Biggest YoY gain for Notes Payables was 91.82% in 2018; the steepest drop was 96.76% in 2018.
  • Year by year, Notes Payables stood at $1.1 million in 2015, then plummeted by 53.34% to $510391.0 in 2017, then tumbled by 92.11% to $40257.0 in 2018.
  • Business Quant data shows Notes Payables for ASTH at $40257.0 in Q4 2018, $159906.0 in Q3 2018, and $278017.0 in Q2 2018.